Skip to content
Sale!
_Nac_02_alpha

2 Augmented NAC

 150.00

 90.00
Category:

Augmented NAC ื”ื•ื ืชื•ืกืฃ ื”ืชื–ื•ื ื” ื”ื”ื™ื™ื˜ืง ื”ื—ื“ืฉื ื™ ื”ืžื•ืจื›ื‘ N-ืืฆื˜ื™ืœืฆื™ืกื˜ืื™ืŸ ื‘ื˜ื•ื”ืจ ื’ื‘ื•ื”, ื”ืžืขื•ื‘ื“ ื‘ืžื”ืœืš ื”ื™ื™ืฆื•ืจ ืขืœ ืžื ืช ืœื™ื™ืขืœ ืืช ื”ื‘ื™ื˜ื•ื™ ื”ืืœืงื˜ืจื•ืžื’ื ื˜ื™ ืฉืœื• ืขืœ ื™ื“ื™ ืฉื™ืคื•ืจ ื™ื›ื•ืœื•ืช ื”ื”ืคื—ืชื” (ื ื•ื’ื“ ื”ื—ืžืฆื•ืŸ) ืฉืœื•. ืžื•ืžืœืฅ ืžืื•ื“ ืœืฉืœื‘ ื ื˜ื™ืœืช Augmented NAC ืขื ื”ืฉื™ืžื•ืฉ ื‘ืฆืžื™ื“ NAC ืขืœ ืžื ืช ืœื”ื’ื‘ื™ืจ ืืช ื”ื‘ื™ื˜ื•ื™ ื ื•ื’ื“ ื”ื—ืžืฆื•ืŸ.
https://augmentednac.com

ืชื•ืฆืื•ืช ืžืขื‘ื“ื” ืžืจืื•ืช ื“ื ื˜ื•ืจืฆื™ื” ืฉืœ 99% ืฉืœ ื—ืœื‘ื•ืŸ ืกืคื™ื™ืงย ืขื Augmented NACย ืชื•ืš ืคื—ื•ืช ืž-24 ืฉืขื•ืช.
ืื ื ืงืจืื• ื‘ืขื™ื•ืŸ ืืช ื”ืชื•ื›ืŸ ืฉืœ ืืชืจ ZeroSpike ื•ื”-ืฉืืœื•ืช ื”ื ืคื•ืฆื•ืช.

ื›ืœ ืฆื ืฆื ืช Augmented NAC ืžื›ื™ืœื”:
90 ื›ืžื•ืกื•ืช
200 ืžโ€ื’ ื›ืœ ื›ืžื•ืกื”

ืžื™ื ื•ืŸ

Augmented NAC ืžื•ืžืœืฅ ื‘ืžื™ื ื•ื ื™ื ืฉืœ 200 ืžโ€ื’ โ€“ 2 ืคืขืžื™ื ื‘ื™ื•ื, 15 ื“ืงื•ืช ืœืคื ื™ ื”ืืจื•ื—ื•ืช.
*ื—ืฉื•ื‘ ืœื”ืชื™ื™ืขืฅ ืขื ืจื•ืคื ืฉืžื›ื™ืจ ืืช NAC ื‘ื ื•ื’ืข ืœื ื˜ื™ืœืช NACย ื•ื›ื“ื™ ืœื”ืชืื™ื ืืช ื”ืžื™ื ื•ืŸ ืœืžืฆื‘ ื”ืคืชื•ืคื™ื–ื™ื•ืœื•ื’ื™ ืฉืœื›ื.

ืื™ื ืคื•ืจืžืฆื™ื” ื—ืฉื•ื‘ื” Federazione Rinascimento Italia ื•ื”ืžืคื™ืฅ ื”ืฉื•ื•ื™ืฆืจื™ B.A.I. Technologies SA ืฉืœ Augmented NAC ื• ืฆืžื™ื“ NAC ืื™ื ื ืžืฆื™ืขื™ื ืฉื•ื ืฉื™ืจื•ืช ืจืคื•ืื™, ื•ืฉื•ื ื™ื™ืขื•ืฅ ืจืคื•ืื™ ื•ืื™ื ื ืžืฆื™ืขื™ื ื›ืœ ืกื•ื’ ืฉืœ ืชืจื•ืคื”.

ืคืจื•ื™ืงื˜ ZeroSpike ื”ื•ืงื ืืš ื•ืจืง ื›ืคืจื•ื™ืงื˜ ืœืžื˜ืจืช ืžื—ืงืจ ืฉืœ: ื ื’ื™ืฃ Sars-Cov-2, ื˜ื›ื ื•ืœื•ื’ื™ื•ืช mRNA ื”ื—ื“ืฉื•ืช ื•ืชืคืงื™ื“ ื—ืœื‘ื•ืŸ ื”ืกืคื™ื™ืง. ื”ืชื•ืฆืื•ืช ืฉืคื•ืจืกืžื• ืžื‘ื•ืกืกื•ืช ืขืœ ืชื™ืขื•ื“ ืžื“ืขื™ ืฉื–ืžื™ืŸ ืœื›ื•ืœื ื™ื—ื“ ืขื ืชื•ืฆืื•ืช ืžืขื‘ื“ืชื™ื•ืช (in vitro). ื ื›ื•ืŸ ืœื”ื™ื•ื, ื™ืฉ ืจืง ืชื™ืขื•ื“ ืจืคื•ืื™-ืžื“ืขื™ ืกืคื•ืจื“ื™ ืœื’ื‘ื™ ื”ืงื•ืจืœืฆื™ื” ื‘ื™ืŸ “ื—ื™ืกื•ืŸ ืงื•ื‘ื™ื“” ื•ืชื•ืคืขื•ืช ืœื•ื•ืื™ (“ื ื–ืง ืžื”ื—ื™ืกื•ืŸ”), ื•ื›ืŸ ืœื’ื‘ื™ ื“ื ื˜ื•ืจืฆื™ื” ืฉืœ ื—ืœื‘ื•ืŸ ื”ืกืคื™ื™ืง ืขืœ ื™ื“ื™ ืชื•ืกืฃ ื”ืžื–ื•ืŸ NAC ื•ื‘ืื—ื•ื– ืžืฉืžืขื•ืชื™ (100%) ื‘ืขื–ืจืช Augmented NAC. ืชื•ืฆืื•ืช ืžืขื‘ื“ื” ืืœื• ื”ื•ื›ื—ื• ืจืง ื‘ืชื ืื™ ืžืขื‘ื“ื”, ื›ืš ืฉื–ื” ืœื ืื•ืžืจ ืฉื–ื” ื™ื•ื›ืœ ืœืขื–ื•ืจ in vivo ืœืžื™ ืฉื”ื•ืจืขืœ ืžื—ืœื‘ื•ืŸ ื–ื”. ืจืง ืื ืฉื™ ืžืงืฆื•ืข ืจืคื•ืื™ื™ื ื™ื›ื•ืœื™ื ืœื”ืขืจื™ืš ืืช ื”ื”ื™ืกื˜ื•ืจื™ื” ืฉืœ ื”ืžืงืจื” ื”ืื™ืฉื™ ื•ืœื”ืฆื™ืข ื˜ื™ืคื•ืœ ืืคืฉืจื™, ื‘ื™ืŸ ืื ืขืœ ื™ื“ื™ ืชืจื•ืคื•ืช ืื• ืขืœ ื™ื“ื™ ื—ื•ืžืจื™ื ืื—ืจื™ื.

en_GB